AstraZeneca · 1 week ago
Discovery Biology Therapeutic Optimization Intern (PhD)
AstraZeneca is seeking PhD students for a 10-week internship role at their Alexion: AstraZeneca Rare Disease site in New Haven, CT. The role involves developing immunogenicity assays and benchmarking immunogenicity metrics for biologics.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Develop immunogenicity Assays for T cell activation
Benchmark immunogenicity metrics of in vitro, in silico, and clinical data
Develop a risk assessment decision tree for discovery biologics for immunogenicity risk assessment
Qualification
Required
PhD students studying immunology, cell biology, biophysics, biochemistry, molecular biology, or a related discipline
Candidates must have an expected graduation date after August 2026
At least 2 years of experience in a research lab is required
Experience with immunofluorescence assays is required
The ability to keep high levels of housekeeping, safety, and environmental standards in the laboratory is required
US Work Authorization is required at time of application
Ability to report onsite to our New Haven, CT 4-5 days per week. This role will not provide relocation assistance
Preferred
Experience in mammalian tissue culture is preferred
Completed coursework in immunology is preferred
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-14
Company data provided by crunchbase